Peptides for Climbers: A2 Pulley and Chalk Skin

The Pop on the Crimp

Every climber who pushes grade eventually meets the A2 pulley. And every climber who chalks up day after day eventually meets the other injury nobody writes training plans for: skin that dries, cracks, and splits at the tips until it limits sessions as hard as any tendon does. Both problems are connective-tissue problems at root, and both are slow to heal for the same reason. This guide is about where peptide therapy might support each of them, organized the way climbers actually experience the injuries, and honest about where the science is real and where it is hopeful.

What the A2 Pulley Actually Is

The finger pulleys are bands of fibrous tissue that hold the flexor tendons close to the bone as the finger curls. Without them, the tendons would bowstring away from the finger when you make a fist. The A2 pulley, at the base of the finger, takes the most load of any of them, and the crimp grip that climbing depends on is uniquely brutal on it. In a full crimp, the forces on the A2 can reach three to four times the force at the fingertip. No other common activity loads this small structure the way hard climbing does.

Pulley injuries are graded. A grade I is a strain or microtearing. Grade II is a partial tear. Grade III is a complete rupture of a single pulley, and grade IV is multiple pulleys torn, often with visible bowstringing of the tendon. The reason any of this heals slowly is structural: the pulley is dense, fibrous, and poorly vascularized. Tissue with a poor blood supply does not get the rapid delivery of healing factors that well-perfused tissue does, which is exactly the bottleneck that an angiogenesis-promoting approach is theorized to address.

Why Rest-and-Collagen Falls Short

The standard advice is rest, then load progressively, and maybe take collagen. The rest-and-load part is correct and non-negotiable: the climbing-medicine literature, from the rehab protocols climbers actually follow, is built on progressive loading once the acute phase passes. The weak link is the collagen part, which gets oversold. Oral collagen supplies amino acids, generic raw material the body can use anywhere. It does not deliver a targeted signal to a specific poorly vascularized pulley telling it to heal faster.

It also does nothing for the second half of the climber problem, the skin. The standard skin advice (sand the calluses, use a salve, file the splits) manages symptoms on the surface. None of it addresses the barrier repair underneath. So the climber ends up with two slow connective-tissue problems and a toolkit of generic, surface-level interventions. That gap is where the targeted-peptide conversation belongs, with appropriate caution about what is proven.

The Three Peptides in Scope

The peptides that come up for climbers are BPC-157, the BPC/TB-500 combo, and GHK-Cu. All three are prescription-only in the US and subcutaneous injections, and all require evaluation by a licensed provider.

Two details worth pulling out of the table. One study reported BPC-157 increasing growth-hormone receptor expression in tendon fibroblasts, a plausible piece of the repair picture for a slow-healing structure. And the GHK-Cu caveat: it can be drying initially for some people, so it works best alongside a ceramide or hyaluronic-acid moisturizer rather than on its own.

The Pulley: Grade by Grade

The realistic way to think about peptide timing is around the grade of the injury and the rehab phase, not as a fixed protocol. The structural healing follows the same inflammatory, proliferative, and remodeling arc as any connective-tissue injury, the same arc that governs a skier rebuilding an ACL graft, and the proposed peptide mechanisms line up most closely with the proliferative and remodeling phases, when new tissue is being built and organized.

Taping and the Return to Crimping

During the return-to-climbing phase, H-taping is the mechanical complement to whatever tissue support you are using. Placed correctly, close to the joint in the figure-eight or H pattern, taping has biomechanical evidence behind it: systematic-review data suggests it can reduce pulley bowstringing on the order of 15 to 22 percent. That is meaningful protection for a healing pulley taking its first real loads again.

The mental model worth holding is division of labor. The tape manages the mechanical load on the healing structure. The progressive loading protocol provides the stimulus that tells the tissue how to organize. The peptides, if your provider has prescribed them, are the background tissue-support layer underneath both. None of the three replaces the others, and the tape and the loading protocol are the parts with the strongest evidence.

The Skin Nobody Talks About

Skin is the injury climbing training plans ignore and climbing sessions revolve around. Chalk pulls moisture out of the skin, friction on rock and plastic abrades it, and the result for high-volume climbers is fingertips that dry, glass over, and split. A split tip can shut down a session as hard as a tweaked tendon, and the standard fixes (sanding, salves, filing) are surface-level symptom management. They do not rebuild the barrier.

This is the one place in the guide where the human evidence is actually strong. GHK-Cu has a real research record in skin barrier repair and collagen organization. Reframed from its usual face-and-anti-aging marketing toward the climber problem, it is a barrier-repair tool for chronically chalk-stressed hands. The honest caveat bears repeating: copper peptides can be drying initially for some people, so the sensible use is alongside a ceramide or hyaluronic-acid moisturizer as part of a skin routine, not as a standalone miracle for split tips. Used that way, it addresses the underlying barrier rather than just buffing the surface.

Real-World Logistics

All three peptides are subcutaneous injections, the standard shallow insulin-needle technique used across peptide therapy, taking about thirty seconds. PeRx ships them fully reconstituted and ready to use, stored refrigerated at 36 to 46 degrees Fahrenheit. For climbers who travel to crags and comps, the vials are prescription medications in labeled packaging and hold their temperature window for 24 to 48 hours in a soft cooler with frozen gel packs, which covers a road trip to the desert or a weekend at a bouldering destination.

On sequencing: the tissue-support peptides are typically dosed daily through the active healing window of a pulley injury, at a consistent time of day, rather than timed around climbing sessions. The mechanisms work on a days-to-weeks timescale, so there is no benefit to injecting right before you climb. For the skin side, GHK-Cu fits into a normal daily routine. The thing to actually time around your sessions is the load: the rehab and the return-to-crimp progression, not the injection.

What Peptides Will Not Do for a Pulley

Four honest distinctions, because finger injuries make climbers desperate and desperation is where the overselling lives.

It will not let you climb through a pulley injury. Nothing does. The tissue needs reduced load to heal, and the single biggest determinant of recovery is whether you actually back off the aggravating grip. A peptide is not a permission slip to keep projecting on a torn pulley.

It will not beat rehab and taping on evidence. The progressive loading protocol and H-taping are the parts of this with the strongest support. The peptides are an adjunct layer, and for the tendon side the evidence is preclinical, not proven in humans.

It will not fix a full rupture on its own. A grade III or IV pulley injury, especially with bowstringing, may need a hand specialist and sometimes surgery. That is a medical evaluation, not a peptide decision.

It is not an option for tested competition. BPC-157 and TB-500 are on the WADA Prohibited List and are FDA-unapproved. If you compete in IFSC or any tested event, they are off the table during your season. They are prescribed for recreational adult climbers who are not subject to anti-doping testing.

Questions Climbers Ask